Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects 2021-08-03 20:06
Clinical Trial Affirms CoviDTH Diagnostic Approach to screen for T cell-mediated immune response to SARS-CoV-2 is safe and effective in humans 2021-08-03 20:00
Angel Yeast Reports Strong Revenue Growth in First Half of 2021, Achieves 20.55% YoY Increase 2021-08-03 15:54
Nanoform and Boehringer Ingelheim execute master services agreement 2021-08-03 14:28
GenScript Joins Forces with Allozymes by Providing Smart Libraries Construction for Precision Protein Engineering 2021-08-03 12:05
CStone announces positive registrational study of the first-in-class drug ivosidenib in Chinese patients with relapsed or refractory acute myeloid leukemia, and NDA has been accepted by the China NMPA and considered for Priority Review 2021-08-03 08:05
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate 2021-08-02 20:13
Happiness Biotech Announced Financial Results for Fiscal Year Ended March 31, 2021 2021-08-02 20:00
Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets 2021-08-02 18:45
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO 2021-08-02 18:00
Bionomics Announces Plans to Conduct U.S. Initial Public Offering 2021-08-02 18:00
Hummingbird Bioscience Announces UK MHRA Approval for First-in-Human Phase 1 Trial of HMBD-001 in Advanced Cancers 2021-08-02 17:00
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines 2021-08-02 15:25
Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-08-02 14:00
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic 2021-08-02 11:11
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma 2021-08-02 07:29
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report 2021-07-30 21:05
I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease 2021-07-30 20:00
EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine 2021-07-30 15:33
Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets. 2021-07-30 08:00
1 230 231 232 233 234 451